Alnylam Pharmaceuticals, Inc. (ALNY)
330.60
+11.75
(+3.69%)
USD |
NASDAQ |
Apr 06, 14:12
Alnylam Pharmaceuticals SG&A Expense (TTM) : 1.211B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Eli Lilly & Co. | 11.09B |
| Bristol Myers Squibb Co. | 7.267B |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |